Inventor · disambiguated record
Daniella Ishimaru
Also filed as: ISHIMARU DANIELLA
6 granted patents·12 pending applications·14 citations·filing 2018–2024
79Inventor score
Top patents by PatentIndex Score
18 records- 0194US11786610B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2022·Granted Oct 17, 2023·4 cites·20 claims
- 0294US11510997B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2022·Granted Nov 29, 2022·5 cites·26 claims
- 0390US11642421B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2020·Granted May 9, 2023·2 cites·65 claims
- 0489US12133923B2Lipid nanoparticle compositions and uses thereofRECODE THERAPEUTICS INC·Filed 2024·Granted Nov 5, 2024·2 cites·25 claims
- 0588US12337068B2Lipid nanoparticle compositions and uses thereofRECODE THERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·1 cites·28 claims
- 0681US2024285798A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2023·Application pending·0 cites
- 0780US12257318B2Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Granted Mar 25, 2025·0 cites·30 claims
- 0879US2025276091A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0979US2024299310A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1079US2024277850A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1179US2024261432A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1278US2024245619A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1372US2024398983A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1470US2019117796A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2018·Application pending·0 cites
- 1570US2019111074A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2018·Application pending·0 cites
- 1668US2025019409A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1755US2025114477A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1853US2024123087A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniella Ishimaru files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →